22 related articles for article (PubMed ID: 21240990)
1. NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis.
Gao Y; Wan L; Li M; Wang B; Ma Y
Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma.
Matani H; Sahu D; Paskewicz M; Gorbunova A; Omstead AN; Wegner R; Finley GG; Jobe BA; Kelly RJ; Zaidi AH; Goel A
Biomark Res; 2022 Nov; 10(1):81. PubMed ID: 36376989
[TBL] [Abstract][Full Text] [Related]
3. Systematic Analysis of Molecular Characterization and Clinical Relevance of Liquid-Liquid Phase Separation Regulators in Digestive System Neoplasms.
Zhang Y; Li J; Feng D; Peng X; Wang B; Han T; Zhang Y
Front Cell Dev Biol; 2021; 9():820174. PubMed ID: 35252219
[No Abstract] [Full Text] [Related]
4. Association between TP53 gene deletion and protein expression in esophageal squamous cell carcinoma and its prognostic significance.
Niyaz M; Ainiwaer J; Abudureheman A; Zhang L; Sheyhidin I; Turhong A; Cai R; Hou Z; Awut E
Oncol Lett; 2020 Aug; 20(2):1855-1865. PubMed ID: 32724429
[TBL] [Abstract][Full Text] [Related]
5. GADD45A expression is correlated with patient prognosis in esophageal cancer.
Ishiguro H; Kimura M; Takahashi H; Tanaka T; Mizoguchi K; Takeyama H
Oncol Lett; 2016 Jan; 11(1):277-282. PubMed ID: 26870203
[TBL] [Abstract][Full Text] [Related]
6. KLHL39 suppresses colon cancer metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination.
Chen HY; Hu JY; Chen TH; Lin YC; Liu X; Lin MY; Lang YD; Yen Y; Chen RH
Oncogene; 2015 Oct; 34(40):5141-51. PubMed ID: 25619834
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.
Chen M; Huang J; Zhu Z; Zhang J; Li K
BMC Cancer; 2013 Nov; 13():539. PubMed ID: 24206575
[TBL] [Abstract][Full Text] [Related]
8. p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Karashima R; Imamura Y; Ida S; Ishimoto T; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
Med Oncol; 2013 Dec; 30(4):728. PubMed ID: 24026664
[TBL] [Abstract][Full Text] [Related]
9. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
10. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery.
Yen CC; Tsao YP; Chen PC; Wu YC; Liu JH; Pan CC; Liu CY; Tzeng CH; Chen PM; Chen YJ; Lin CH; Hsu WH
J Surg Oncol; 2011 Jun; 103(8):761-7. PubMed ID: 21240990
[TBL] [Abstract][Full Text] [Related]
11. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of NBS1 and Snail expression in esophageal squamous cell carcinoma.
Kuo KT; Chou TY; Hsu HS; Chen WL; Wang LS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S549-57. PubMed ID: 21881923
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
